Randomized Phase II Study Comparing Efficacy and Safety of...

Clinical Breast Cancer 2011 Vol. 11; Iss. 2

Randomized Phase II Study Comparing Efficacy and Safety of Combination-Therapy Trastuzumab and Docetaxel vs. Sequential Therapy of Trastuzumab Followed by Docetaxel Alone at Progression As First-Line Chemotherapy in Patients with HER2+ Metastatic Breast Cancer: HERTAX Trial

Paul Hamberg, Monique M.E.M. Bos, Hans J.J. Braun, Jacqueline M.L. Stouthard, Gert A. van Deijk, Frans L.G. Erdkamp, Iris N. van der Stelt-Frissen, Marijke Bontenbal, Geert-Jan M. Creemers, Johanneke
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
11
Year:
2011
Language:
english
Pages:
11
DOI:
10.1016/j.clbc.2011.03.003
File:
PDF, 1.26 MB
english, 2011
Conversion to is in progress
Conversion to is failed